Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Postmarketing Study of Amlodipine/Valsartan Single-Pill Combination for the Treatment of Hypertension

NCT02058446 is registered in ClinicalTrials.gov with TSH Biopharm Corporation Limited as lead sponsor.

NCT NCT02058446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Postmarketing Study of Amlodipine/Valsartan Single-Pill Combination for the Treatment of Hypertension
Lead sponsor
TSH Biopharm Corporation Limited
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
March 31, 2014
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension